News

For first-year Weill Cornell Graduate School of Medical Sciences doctoral student Suniyya Amna Waraich, developing new therapies for stroke patients is personal: A close relative was at a family gathering when he had a stroke. Fortunately, the doctors in her family were able to diagnose it early, she said, he has recovered well as a result.

“But even in his case, the weight of constant wariness and anticipation of another stroke is impossible to shake,” said Waraich, who is studying...

New studies from Weill Cornell Medicine researchers have revealed the importance of two gene-regulation proteins in the development of common immune cell cancers called lymphomas.

The studies, published Dec. 10 in Nature Immunology and Oct. 1 in Cancer Discovery, showed that one of the proteins, LSD1, plays a major role in starting and sustaining...

In 2013, scientists at MIT and at UC Berkeley optimized a way to use bacterial gene sequences to cut and change DNA at precise locations. The genome-editing system, called CRISPR, is cheaper and simpler than previous methods, and it has led to breakthroughs in diagnostics and the creation of more accurate disease models. And because it can permanently modify a living organism’s DNA, CRISPR technology may one day allow physicians to treat genetic diseases—anything from congenital deafness to...

By Molly Schulson
Illustrations by Aaron Sacco

For three Weill Cornell Medicine summer training programs—all dedicated to helping socioeconomically disadvantaged or minority undergraduates explore careers in the medical sciences—this is a milestone year. Two of them, Advancing Cornell Career Experiences for Science Students (ACCESS) and Gateways to the Laboratory, mark 25 years of service, while the Travelers Summer Research Fellowship celebrates 50. All three provide...